Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of CMV/EBV-CMI in Haploid HSCT
Sponsor: The First Affiliated Hospital of Soochow University
Summary
The purpose of this prospective, open-label, Single Arm, single-center study is to evaluate the cytomegalovirus and Epstein-Barr virus specific immune reestablishment for patients with hemopathy undergoingin prophylaxis for cytomegalovirus in haploid hematopoietic stem cell transplantation(haplo-HSCT) .
Official title: Evaluation of Cytomegalovirus and Epstein-Barr Virus Specific Immune Reformulation in Prophylaxis for Cytomegalovirus in Haploid Hematopoietic Stem Cell Transplantation
Key Details
Gender
All
Age Range
16 Years - 60 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2024-08-13
Completion Date
2026-07-31
Last Updated
2024-08-15
Healthy Volunteers
No
Conditions
Interventions
CMV/EBV-CMI
The CMV/EBV-CMI is tested before conditioning regimen and 30 days, 45 days, 60 days, 90 days, 120 days, 180 days after transplantation.
Locations (1)
First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China